Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clotting Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT01125813
What this trial is testing

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 32
Large-scale testing (Phase 3)Study completedNCT00183001
What this trial is testing

Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification

Who this might be right for
OsteoporosisVascular CalcificationInflammation
National Institute on Aging (NIA) 452
Large-scale testing (Phase 3)Active Not RecruitingNCT05047172
What this trial is testing

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Who this might be right for
Intracranial ArteriosclerosisStroke
University of Florida 1,683
Not applicableStudy completedNCT04731701
What this trial is testing

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 180
Not applicableStudy completedNCT00776412
What this trial is testing

Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

Who this might be right for
InflammationPathologic Processes
National Institute of Allergy and Infectious Diseases (NIAID) 310
Testing effectiveness (Phase 2)Ended earlyNCT00726544
What this trial is testing

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyThrombotic Thrombocytopenic Purpura
Archemix Corp. 100
Testing effectiveness (Phase 2)Ended earlyNCT03597022
What this trial is testing

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Who this might be right for
Hemophilia A and B
Bayer 24
Not applicableLooking for participantsNCT06610201
What this trial is testing

Bleeding and Treatment in Participants With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease (VWD)Von Willebrand Disease (VWD), Type 1Von Willebrand Disease (VWD), Type 2+4 more
Hemab ApS 200
Testing effectiveness (Phase 2)Ended earlyNCT02586012
What this trial is testing

Weight-based Dosing in Hemophilia A

Who this might be right for
Hemophilia
Craig Seaman 30
Testing effectiveness (Phase 2)Looking for participantsNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Not applicableStudy completedNCT01064336
What this trial is testing

Promacta Pregnancy Registry

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 1
Not applicableUnknownNCT04507711
What this trial is testing

Palonosetron and Blood Coagulation

Who this might be right for
Blood Coagulation Disorder
Seoul National University Bundang Hospital 12
Large-scale testing (Phase 3)Study completedNCT02111564
What this trial is testing

Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

Who this might be right for
Heart FailureRespiratory InsufficiencyStroke Acute+2 more
Janssen Research & Development, LLC 12,024
Testing effectiveness (Phase 2)Study completedNCT00111475
What this trial is testing

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 45
Large-scale testing (Phase 3)WithdrawnNCT01734057
What this trial is testing

Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University
Not applicableStudy completedNCT02604602
What this trial is testing

Coagulation Factors and Postpartum Hemorrhage

Who this might be right for
Postpartum Hemorrhage
University of Zurich 1,500
Large-scale testing (Phase 3)Ended earlyNCT00387192
What this trial is testing

A Study With OPTIVATE® in People With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
Bio Products Laboratory 26
Early research (Phase 1)Study completedNCT01439971
What this trial is testing

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Who this might be right for
Hemophilia A
Catalyst Biosciences 29
Post-approval studies (Phase 4)Study completedNCT00351663
What this trial is testing

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients

Who this might be right for
Venous ThrombosisCritical Illness
Shaare Zedek Medical Center 39
Next Page